In the latest trading session, 1.89 million Cassava Sciences Inc (NASDAQ:SAVA) shares changed hands as the company’s beta touched -1.01. With the company’s most recent per share price at $2.63 changing hands around $0.28 or 12.13% at last look, the market valuation stands at $130.09M. SAVA’s current price is a discount, trading about -1504.56% off its 52-week high of $42.20. The share price had its 52-week low at $2.23, which suggests the last value was 15.21% up since then. When we look at Cassava Sciences Inc’s average trading volume, we note the 10-day average is 3.17 million shares, with the 3-month average coming to 5.14 million.
Analysts gave the Cassava Sciences Inc (SAVA) stock a consensus recommendation rating of Hold, calculated at a mean rating of 3.67. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended SAVA as a Hold, 0 felt it is a Buy and 0 rated the stock as Underweight. Cassava Sciences Inc’s EPS for the current quarter is expected to be -0.68.
Cassava Sciences Inc (NASDAQ:SAVA) trade information
Instantly SAVA is in green as seen in intraday trades today. With action -0.94%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -88.29%, with the 5-day performance at -0.94% in the red. However, in the 30-day time frame, Cassava Sciences Inc (NASDAQ:SAVA) is -91.81% down. Looking at the short shares, we see there were 17.16 million shares sold at short interest cover period of 1.95 days.
Cassava Sciences Inc (SAVA) estimates and forecasts
Data shows that the Cassava Sciences Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -86.34% over the past 6 months, a 31.90% in annual growth rate that is considerably higher than the industry average of 16.40%.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -30.45%. The 2024 estimates are for Cassava Sciences Inc earnings to increase by 62.79%.
SAVA Dividends
Cassava Sciences Inc is expected to release its next quarterly earnings report in January.
Cassava Sciences Inc (NASDAQ:SAVA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 12.65% of Cassava Sciences Inc shares while 29.93% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 34.27%. There are 29.93% institutions holding the Cassava Sciences Inc stock share, with BLACKROCK INC. the top institutional holder. As of 2024-06-30, the company held 7.4874% of the shares, roughly 3.22 million SAVA shares worth $39.76 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 6.2397% or 2.68 million shares worth $33.14 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. With 1.28 shares estimated at $3.25 million under it, the former controlled 2.65% of total outstanding shares. On the other hand, iShares Russell 2000 ETF held about 2.17% of the shares, roughly 1.05 shares worth around $2.67 million.
